Abacavir/zidovudina/lamivudina

Resumen

Alternativas con registro en Colombia

• Lamivudina Y Zidovudina
• Lamivudina Y Abacavir
• Tenofovir Disoproxil Y Emtricitabina
• Efavirenz. Tenofovir Disoproxil Y Emtricitabina
• Emtricitabina. Tenofovir Disoproxil Y Rilpivirina
• Emtricitabina. Tenofovir Disoproxil. Elvitegravir Y Cobicistat
• Lopinavir Y Ritonavir
• Lamivudina. Tenofovir Disoproxil Y Efavirenz
• Lamidubina. Abacavir Y Dolutegravir
• Darunavir Y Cobicistat
• Emtricitabina Y Tenofovir Alafenamida
• Elvitegravir. Cobicistat. Emticitabina. Tenofovir Alafenamida

Estudios clínicos principales

• Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir
  Fase 3 · 2008 · 724 participantes · Gilead Sciences · NCT00708162 · PubMed 22015077
• BRAAVE 2020: Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of
  Fase 3 · 2018 · 496 participantes · Gilead Sciences · NCT03631732 · PubMed 34397746
• PROTEA: A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/N
  Fase 3 · 2012 · 274 participantes · Janssen-Cilag International NV · NCT01448707
• Clinical Trial of CNS-targeted HAART (CIT2)
  Fase 2/3 · 2007 · 59 participantes · University of California, San Diego · NCT00624195 · PubMed 24352352

Enfermedades relacionadas

• Tuberculosis
• VIH

Fuentes

• Etiqueta FDA (DailyMed): ABACAVIR, LAMIVUDINE AND ZIDOVUDINE
• EMA: Trizivir